Press Releases

Press Releases

TFF Pharmaceuticals to Present at April 2020 Virtual Investor Summit

April 17, 2020

TFF Pharmaceuticals to Present at April 2020 Virtual Investor Summit

TFF Pharmaceuticals Announces Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) for use of its Thin Film Freezing Technology Platform

April 15, 2020

TFF Pharmaceuticals Announces Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) for use of its Thin Film Freezing Technology Platform

TFF Pharmaceuticals Announces R&D Collaboration with the University of Georgia for a Universal Influenza Vaccine

April 9, 2020

TFF Pharmaceuticals Announces R&D Collaboration with the University of Georgia for a Universal Influenza Vaccine

UT News: New Delivery Method Could Make Niclosamide an Effective Antiviral to Treat COVID-19

April 6, 2020

UT News: New Delivery Method Could Make Niclosamide an Effective Antiviral to Treat COVID-19

TFF Pharmaceuticals Reports Fourth Quarter Results and Full Year 2019 Financial and Business Results

March 26, 2020

TFF Pharmaceuticals Reports Fourth Quarter Results and Full Year 2019 Financial and Business Results

TFF Pharmaceuticals Reschedules Fourth Quarter and Full-Year 2019 Financial and Business Results Conference Call for March 26, 2020 to 4:30 PM (EDT)

March 23, 2020

TFF Pharmaceuticals Reschedules Fourth Quarter and Full-Year 2019 Financial and Business Results Conference Call for March 26, 2020 to 4:30 PM (EDT)

TFF Pharmaceuticals to Hold Fourth Quarter and Full-Year 2019 Financial and Business Results Conference Call on March 26, 2020

March 19, 2020

TFF Pharmaceuticals to Hold Fourth Quarter and Full-Year 2019 Financial and Business Results Conference Call on March 26, 2020

TFF Pharmaceuticals Announces Phase 1 Clinical Trial Progress for Voriconazole Inhalation Powder to Treat Invasive Pulmonary Aspergillosis (IPA)

March 19, 2020

TFF Pharmaceuticals Announces Phase 1 Clinical Trial Progress for Voriconazole Inhalation Powder to Treat Invasive Pulmonary Aspergillosis (IPA)

TFF Pharmaceuticals Announces Engagement of J.S. Cole & Associates as Strategic Advisor for Partnering Efforts in Japan

March 12, 2020

TFF Pharmaceuticals Announces Engagement of J.S. Cole & Associates as Strategic Advisor for Partnering Efforts in Japan

TFF Pharmaceuticals Announces Engagement of Torreya Partners, LLC as Strategic Advisor for Partnering Efforts in China and South Korea

March 9, 2020

TFF Pharmaceuticals Announces Engagement of Torreya Partners, LLC as Strategic Advisor for Partnering Efforts in China and South Korea

Displaying 31 - 40 of 54
Top